2011•Unpublished venueRequires access

Matrix Gla protein: the inhibitor of vascular and osteoarticular calcifications.

Ciprian Nicolae Silaghi, Alexandra Marioara Craciun, Victor Cristea

Open publisher page 3 citations

Abstract

Ectopic vascular calcification is a cardiovascular risk factor. This phenomenon is no longer regarded as a simple precipitation of calcium phosphate in the extracellular matrix, but it is considered to be the result of an active process similar to bone mineralization. Also, calcium is deposited at osteoarticular level as calcium phosphate or hydroxy-apatite crystals, initially leading to the formation of articular and periarticular asymptomatic deposits. Ectopic calcification inhibitors play a central role in the association of vascular calcification with reduced bone mineral density, a phenomenon called “calcification paradox”. Matrix Gla-protein (MGP) is a local inhibitor of ectopic calcifications. This paper reviews up-to-date information about the fundamental aspects, the determination methods and the clinical implications of MGP in vascular and osteoarticular pathology.

About this research paper

What this paper is about

Ectopic vascular calcification is a cardiovascular risk factor. This phenomenon is no longer regarded as a simple precipitation of calcium phosphate in the extracellular matrix, but it is considered to be the result of an active process similar to bone mineralization. Also, calcium is deposited at osteoarticular level as calcium phosphate or hydroxy-apatite crystals, initially leading to the formation of articular and periarticular asymptomatic deposits. Ectopic calcification inhibitors play a central role in the association of vascular calcification with reduced bone mineral density, a phenomenon called “calcification paradox”. Matrix Gla-protein (MGP) is a local inhibitor of ectopic calcifications. This paper reviews up-to-date information about the fundamental aspects, the determination methods and the clinical implications of MGP in vascular and osteoarticular pathology.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Ectopic vascular calcification is a cardiovascular risk factor. This phenomenon is no longer regarded as a simple precipitation of calcium phosphate in the extracellular matrix, but it is considered to be the result of an active process similar to bone mineralization. Also, calcium is deposited at osteoarticular level as calcium phosphate or hydroxy-apatite crystals, initially leading to the formation of articular and periarticular asymptomatic deposits. Ectopic calcification inhibitors play a central role in the association of vascular calcification with reduced bone mineral density, a phenomenon called “calcification paradox”. Matrix Gla-protein (MGP) is a local inhibitor of ectopic calcifications. This paper reviews up-to-date information about the fundamental aspects, the determination methods and the clinical implications of MGP in vascular and osteoarticular pathology.

Key concepts: Ectopic calcification, Matrix gla protein, Calcification, Calcium, Osteocalcin, Calcinosis, Extracellular matrix, Medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Matrix Gla protein: the inhibitor of vascular and osteoarticular calcifications. — Research Paper | ScholarLens